Numerous players are pitching into the fight against COVID-19, with pharma and biotech companies, governments, academic institutions, nonprofits and others working on tests to diagnose the disease and developing vaccines to prevent it. The third piece of the puzzle, is of course, treating infection.
In this webcast, experts will discuss therapeutics in the works, whether repurposed old drugs or brand new ones. They’ll address the challenges to their development and deployment, and sketch out typical timelines for the types of therapies in testing, or near it. The panel will also cover how outbreak response has evolved over the years, highlight lessons from previous outbreaks, and consider what is different about this one.